Fig. 2From: Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registryUnadjusted treatment outcomes for the overall cohort and stratified per treatment regimen. # Fifteen patients discontinued treatment prematurely but achieved an SVR24; eleven patients treated with TPV/PR and four patients treated with BOC/PR. These patients were counted in both the discontinuation rate and the SVR rateBack to article page